Strong CAGR to Propel in the Pharmaceutical Lipid-Based Excipients Market and Beyond upto $2.22 Billion by 2029
We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Are the Projected Market Size and Growth Rates for the Pharmaceutical Lipid-Based Excipients Market From 2025 To 2029?
In recent times, there has been substantial growth in the size of the pharmaceutical lipid-based excipients market. The market, which was valued at $1.69 billion in 2024, is projected to expand to $1.79 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. The surge during the historical period can be linked to several factors such as the rise of drugs that are poorly soluble in water, the growing demand for targeted and controlled drug release, increasing investments in the pharmaceutical sector, the widespread usage of oral solid dosage forms, a heightened emphasis on enhancing drug bioavailability, and the regulatory approval of lipid excipients in novel formulations.
In the coming years, the market size for pharmaceutical lipid-based excipients is anticipated to witness significant expansion. The projection is for it to reach $2.22 billion in 2029, with a compound annual growth rate (CAGR) of 5.5%. Several factors could contribute to growth during the projected period such as an increased demand for cutting-edge drug delivery systems, rising usage of mRNA and gene therapies, swelling pipeline for drugs with poor water solubility, a heightened emphasis on individualized medicine, beneficial regulatory oversight, and strategic capital injections in biopharmaceutical manufacturing infrastructure. Noteworthy trends throughout this period include advancements in lipid nanoparticle delivery systems, the embracement of mRNA and gene therapies, upgraded solubility solutions for poorly water-soluble drugs, the broadening of biocompatible and eco-friendly lipid sources, improved manufacturing scalability, and wider usage in oral and injectable formulations.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp
Which Primay Drivers Are Accelerating Growth in the Pharmaceutical Lipid-Based Excipients Market?
The growth of the pharmaceutical lipid-based excipients market is anticipated to be driven by the advancement in gene therapy. Gene therapy is a cutting-edge medical approach that manipulates or alters a person’s genes to battle or avert illnesses. The surge in popularity of gene therapy is primarily due to the progress of delivery systems that guarantee safe, efficient, and focused transportation of genetic materials into cells. Pharmaceutical lipid-based excipients play a crucial role in improving gene therapy as they facilitate efficient delivery systems, ensure stability and maintain targeted transport of genetic materials. The therapeutic outcomes are improved as these excipients protect nucleic acids and boost cellular uptake, thereby enhancing the potency of contemporary treatments. For example, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a notable non-profit medical and scientific organization in the United States, noted that the Food and Drug Administration (FDA) has increased gene therapy product approvals from five in 2022 to six in 2023. Consequently, the pharmaceutical lipid-based excipients market’s growth is propelled by the expansion in gene therapy.
Which Primary Segments of the Pharmaceutical Lipid-Based Excipients Market Are Driving Growth and Industry Transformations?
The pharmaceutical lipid-based excipients market covered in this report is segmented –
1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types
2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications
3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications
4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)
5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users
Subsegments:
1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils
2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils
3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC
4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats
5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs
6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids
7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate
8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides
9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids
Request customized data on this market:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp
Which Regions Are Key Players in the Growth of the Pharmaceutical Lipid-Based Excipients Market?
Europe was the largest region in the pharmaceutical lipid-based excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Pharmaceutical Lipid-Based Excipients Industry Dynamics?
Major pharmaceutical lipid-based excipients market players are prioritizing strategic investments aimed at establishing cutting-edge Centers of Excellence to propel innovation, augment formulary skills, back drug delivery research, and boost their competitive edge in burgeoning therapeutic fields. A case in point is Gattefossé SAS, a chemical manufacturing firm from France. In November 2024, the company opened a state-of-the-art Technical Center of Excellence in Mumbai, India, aiming to support the escalating pharma market in the country. The center offers dedicated labs and personalized assistance for excipient innovation, concentrating on bioavailability, sustained release, and topical formulations, thereby fortifying its footprint in the Asia-Pacific market. This ultra-modern facility features pharmaceutical and personal care application labs designed to stimulate innovation, promote teamwork, and offer a conducive working atmosphere.
View the full report here:
What Parameters Are Used to Define the Pharmaceutical Lipid-Based Excipients Market?
Pharmaceutical lipid-based excipients are non-active (inactive) substances derived from lipids used in drug formulations to help deliver, stabilize, or enhance the absorption of the active pharmaceutical ingredient (API). Pharmaceutical lipid-based excipients aim to improve drug solubility, stability, and bioavailability, particularly for poorly water-soluble drugs.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/customise?id=24374&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
